{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "RXO",
  "name": "RXO, Inc.",
  "url": "https://frontierpicks.com/dossiers/RXO/",
  "json_url": "https://frontierpicks.com/dossiers/RXO.json",
  "status": "HELD",
  "current_conviction": "MEDIUM",
  "graded_conviction": "MEDIUM",
  "archetype": {
    "code": "a1",
    "n": 1
  },
  "current_thesis": "Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.",
  "invalidation_trigger": "A weekly close below $24 loses the May–June breakout shelf and consolidation base; secondary breaks are Q2 adjusted EBITDA (~2026-08-05) printing below the $27–37M guide floor, or the RXO Curve spot index rolling over.",
  "catalyst_date": "2026-08-26",
  "outcome": "INVALIDATED",
  "outcome_date": "2026-07-28",
  "invalidation_fired": true,
  "themes": [
    "freight-logistics",
    "cyclical-industrials",
    "managed-care-health-services"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Asset-light broker with low gross margin levered to the truckload spot cycle; earnings power tracks the cycle rather than compounding through it.",
    "Beta near 1.9 — sector and index moves land amplified both ways; the February 2026 session in which the shares fell 20.45% is the reference point.",
    "An up-cycle consumes working capital at this model; Q2 2026 disclosure carried a ~$70M working-capital drag and 4.1x bank-adjusted net leverage.",
    "Casualty spend of roughly $15–20M a year with a $5M per-occurrence deductible is the only RXO figure publicly quantified against broker-liability exposure.",
    "RXO is not a party to Lipe v. Lupus Superior — the $604M verdict sits with C.H. Robinson — but the broker cohort is discounted against its outcome."
  ],
  "body_markdown": "## Current Thesis\n\nThe leg an investor is buying in RXO has a mechanical shape: an asset-light broker carrying almost no fixed cost absorbs a truckload spot squeeze, so a few cents of linehaul movement becomes a step-change in EBITDA. Q2 proved the mechanism — adjusted EBITDA of $40M against a $27–37M guide, revenue $1.774B versus $1.603B consensus, adjusted EPS $0.06 versus $0.03 (release, 2026-08-06). What the tape is now pricing is the input stalling. DAT's week-34 dry van reading put spot linehaul at $2.21 per mile, down $0.04 week-over-week and a fourth consecutive weekly decline, after $2.25 for the week ended 2026-08-14. DAT's own 35-day projection, published 2026-08-17, put the line at $2.24 per mile in mid-September inside a ±$0.08 band. The rate has undercut its forecaster's mid-September centre roughly a month early.\n\nPrice followed. The $24 May–June shelf went on the 2026-08-14 weekly close of $23.52; the next week closed $22.54 (2026-08-21); the 2026-08-24 session closed $21.28, roughly a dollar above the 2026-08-06 print-day close of $20.24 that forms the floor of the post-earnings range. RSI(14) read 45.7 against 59.0 three sessions earlier — the bounce rolled over mid-range without retesting the shelf it lost. The shares sit 27.4% below the $29.30 52-week high, with a three-month price change of -14.9%.\n\n**The narrative is saturated.** Consensus was $24.47 across 21 analysts on 2026-08-13, $24.47 across 21 on 2026-08-21, and $24.47 across 21 on 2026-08-25 — 5 Strong Buy / 2 Buy / 11 Hold / 1 Sell / 2 Strong Sell, range $13 to $35, median $23. Six actions landed inside two sessions on 2026-08-06–07 (UBS $23, Citi $23 from $30, Truist $28 from $30, TD Cowen $17.50 from $19, Stifel $31, Citizens upgrading with a $30 target). Nothing has been recorded since Wells Fargo maintained Hold at $22 on 2026-08-14 — seven sessions of static, two-sided, fully-distributed coverage while the price fell through the middle of it. That is late-cycle positioning, not a fresh bid. A weekly close under the $20.24 post-print floor would date the flip from saturated to dead.\n\n## Bull Case\n\n- **Q2 2026 adjusted EBITDA $40M against a $27–37M guide**, on revenue of $1.774B versus $1.603B consensus and adjusted EPS $0.06 versus $0.03 (release, 2026-08-06). The operating leverage is real and recent: Q1 2026 adjusted EBITDA was $6M.\n- **The Q3 guide of $35–45M brackets the $40M just delivered**, with brokerage volume guided to low-to-mid single-digit YoY growth and gross profit per load up sequentially again (2026-08-06 call).\n- **July truckload gross profit per load ran +20% YoY**, disclosed on the 2026-08-06 call from outside the reported quarter, after Q2's +11% sequential gain on a 900bp sequential rise in spot mix to 42%.\n- **Mix kept shifting after the quarter closed.** CSO Jared Weisfeld told Deutsche Bank's Chicago Industrials Summit on 2026-08-11 that spot ran roughly 50% of brokerage mix in July, with repricing approaching 20% by late summer.\n- **Capacity is structurally thinner than a year ago.** DAT's 2026-08-17 report showed van load-to-truck at 9.98 versus 5.77 a year earlier, truck posts -26.4% YoY, load posts +27.2% YoY, and linehaul 38.4% above the year-ago week and 25.8% above the nine-year seasonal average of $1.78. Week 34 held the ratio near 9.9 even as the rate slipped.\n- **The short base is large relative to a thin float**: 14,486,044 shares at the 2026-07-31 settlement, 8.85% of float, 6.6 days to cover, down 2.13% from 14,801,430 at 2026-07-15.\n- **The mean sell-side target of $24.47 sits above the 2026-08-24 close of $21.28**, and the high end of the range ($35, BMO) has not been withdrawn.\n\n## Bear Case\n\n- **The rate engine has rolled for four straight weeks.** $2.21/mile in week 34, down $0.04, after $2.25 (-1.3%) for the week ended 2026-08-14. The bull leg was never about the level; it was about the direction, and the direction has changed.\n- **Spot no longer sits above contract.** DAT's monthly release published 2026-08-11 showed July van spot and contract linehaul both at $2.39. A broker's gross profit per load compresses when spot runs through contract, and that spread is now zero on the last published monthly reading.\n- **The forecaster's own floor is close.** The ±$0.08 band around $2.24 puts the lower edge at $2.16 — three cents from the week-34 print, with three weeks still to run to the mid-September horizon.\n- **Cash is going out the door while the cycle runs.** Q2 2026 disclosure carried a ~$70M working-capital drag and 4.1x bank-adjusted net leverage; an up-cycle consumes working capital at this model, so leverage improves last, not first.\n- **Coverage is majority-neutral-to-negative.** Of 21 analysts, 11 Hold, 1 Sell, 2 Strong Sell; the low target is $13 and TD Cowen sits at $17.50 after downgrading to Sell on 2026-07-28 on broker-liability exposure.\n- **Litigation discounts the whole cohort.** The $604M Lipe v. Lupus Superior verdict sits with C.H. Robinson, not RXO, but the multiple applied to asset-light brokers moves with its post-trial path. RXO's only publicly quantified figure against that exposure is casualty spend of roughly $15–20M a year with a $5M per-occurrence deductible.\n- **There is no company-reported checkpoint for two months.** The last RXO-sourced number is the 2026-08-06 release; the next is the Q3 print, estimated late October. Everything between is third-party rate data and beta.\n\n## Setup & Price Structure\n\nThe structure is a broken shelf with no base under it. The $24 May–June consolidation floor was lost on the 2026-08-14 weekly close of $23.52 and has not been retested. The 2026-08-21 close of $22.54 marked the high-water mark of the rebound attempt; the 2026-08-24 close of $21.28 gave it back and then some. The operative level below is the 2026-08-06 print-day close of $20.24, which is where the market marked the stock after a quarter that beat both revenue and EBITDA guidance — a level set on good news, which makes losing it informative rather than noisy.\n\nMomentum confirms the failure without adding much: RSI(14) at 45.7 on 2026-08-24 against 59.0 on 2026-08-21. The oscillator ran into the upper half of the post-print range and turned before clearing it. No higher low has formed since 2026-08-06.\n\nCrowding and positioning observables, stated as observables: 8.85% of float short at the 2026-07-31 settlement with days-to-cover at 6.6, down from 10.7 at 2026-07-15 — the short base shrank on rising volume rather than being squeezed out. Sell-side flow clustered into two sessions (2026-08-06–07, six actions) and then stopped; nothing since 2026-08-14. The mean target has been frozen at $24.47 across three separate readings while the price fell roughly $1.26 over the last two sessions of that window. Beta near 1.9 means index and sector moves land amplified; the February 2026 session in which the shares fell 20.45% is the reference point for how that behaves on a bad tape.\n\n## Catalyst Calendar (next 30 days)\n\n- **2026-08-26 (est.)** — Exchange short-interest publication for the 2026-08-14 settlement.\n- **~2026-08-31 (est.)** — DAT weekly dry van report for week 35. Whether the four-week decline extends and whether linehaul approaches the $2.16 lower band edge.\n- **~2026-08-31 (est.)** — RXO Curve report covering Q2 2026 truckload spot rates. The company's own cycle index; the edition live on rxo.com as of 2026-08-21 still carried Q1 (all-in index 129, spot +16.5% YoY, contract +2.4% YoY, measured through mid-May).\n- **~2026-09-01 (est.)** — Post-trial and appellate filings in Lipe v. Lupus Superior (Dallas County). C.H. Robinson has said it will appeal; whether the trial court enters, reduces or vacates the $604M verdict sets the liability benchmark the broker cohort is discounted against.\n- **~2026-09-10 (est.)** — DAT monthly rate release for August 2026. The July edition, published 2026-08-11, put van spot and contract linehaul both at $2.39; this checks whether spot has slipped below contract.\n- **~2026-09-15 (est.)** — Horizon date of DAT's 35-day forecast of $2.24/mile ±$0.08. A print below $2.16 puts the cycle under its own forecaster's floor.\n- **~2026-09-15 (est.)** — D.C. Circuit oral argument in Rivera Lujan v. FMCSA on the non-domiciled CDL rule, in force since 2026-03-16. It is the regulatory leg of the capacity-tightness argument.\n- **~2026-10-29 (est.)** — Q3 2026 print. Outside the window and the only company-reported checkpoint until then: the $35–45M adjusted EBITDA guide, whether the ~$70M working-capital drag reverses, and whether bank-adjusted net leverage moves off 4.1x.\n\n## What Would Change Our Mind\n\nThe structure that mattered is already gone: the $24 May–June shelf was lost on the 2026-08-14 weekly close of $23.52 and has not been reclaimed, and the rebound failed at $22.54 on 2026-08-21. What remains is the post-print floor. A weekly close below $20.24 takes out the level the market set on 2026-08-06 after a quarter that beat on revenue and EBITDA, and ends the recovery leg as a tradeable structure rather than merely bending it.\n\nOn the fundamental side, the specific datapoint that would break the argument is DAT dry van spot linehaul printing under $2.16 — the lower edge of DAT's own mid-September band — before the ~2026-09-15 horizon. The week-34 reading of $2.21 leaves three cents of room. A second one is the ~2026-09-10 DAT monthly showing August van spot linehaul below contract after both printed $2.39 in July, which compresses gross profit per load directly. On the company side, Q3 adjusted EBITDA landing below the $35–45M guide floor at the ~2026-10-29 print, or bank-adjusted net leverage above 4.1x with the ~$70M working-capital drag unreversed.\n\nWhat would rebuild the case: a weekly close back above $23.52 with linehaul turning up week-over-week, or a fresh upgrade breaking the seven-session silence in the sell-side tape since 2026-08-14 and moving the frozen $24.47 mean.\n\n## Correlation Notes\n\n- Trades with the asset-light brokerage cohort — C.H. Robinson, Landstar, XPO — and with truckload carriers Saia and ArcBest on sector days. The February 2026 session that took RXO down 20.45% also moved Landstar -15.6% and Expeditors -13.18%.\n- The single strongest driver is the DAT dry van spot linehaul series, published weekly on Mondays and monthly around the 10th. Gross profit per load is a spread business, so the spot-minus-contract gap matters more than the absolute rate; both printed $2.39 in July.\n- Litigation beta is shared, not idiosyncratic. The Lipe v. Lupus Superior docket moves the broker multiple as a group regardless of which name is a party.\n- Beta near 1.9 means index drawdowns transmit amplified. Company-specific progress in the rate data can be entirely overwhelmed by a broad industrials move.\n- The regulatory leg — the FMCSA non-domiciled CDL rule in force since 2026-03-16 — is a supply-side input shared with every truckload name; a D.C. Circuit ruling for petitioners would loosen the driver-exit path across the sector.",
  "first_seen": "2026-04-20",
  "last_analyzed": "2026-08-25T04:01:58+00:00",
  "last_synthesized": "2026-08-25",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}